|
AU2018368465A1
|
|
Use of cyanobacterial biomass in treating hepatitis B virus infection
|
|
SG11202001154QA
|
|
Cyanobacterial extracts, processes for preparing the same and uses thereof
|
|
US2016354298A1
|
|
Composition of algal extracts for preventing and treating periodontal disease
|
|
TW201446663A
|
|
Green processing system and method for biodegradable waste
|
|
TW201334684A
|
|
Continuous layered three-dimensional microalgae culturing system
|
|
TW201332557A
|
|
Cyanobacterial extract solution, pharmaceutical composition and use thereof
|
|
TW201221133A
|
|
A medical compositions for inhibition of influenza hemagglutinin and process for the preparation thereof
|
|
CN102462702A
|
|
Medicinal composition capable of restraining influenza virus hemaglutinin (HA) and preparation method thereof
|
|
TW201036620A
|
|
And a composition for assisting the therapeutic effect of the hepatitis B drug
|
|
TW201023752A
|
|
Manufacturing method of green algae product with high digestibility
|
|
TW200610536A
|
|
Pharmaceutical compositions for suppressing influenza virus infection and replication
|
|
TW200526911A
|
|
Method for producing colored ice blocks and applications thereof
|
|
TW200501989A
|
|
Method for marking tumor tissue or cell by using phycoerythrin and test kit thereof
|
|
TW200413728A
|
|
Fluorescent labeling reagent and its kit using B-phycoerythrin (B-PE) and its derivatives
|
